title: Naltrexone treatment of hallucinogen persisting perception disorder.
authors.forename: A G
authors.initials: AG
authors.lastname: Lerner
authors.forename: I
authors.initials: I
authors.lastname: Oyefe
authors.forename: G
authors.initials: G
authors.lastname: Isaacs
authors.forename: M
authors.initials: M
authors.lastname: Sigal
mesh_terms: D000328:Adult; D002648:Child; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects*; D008297:Male; D009271:Naltrexone / Q000627:therapeutic use*; D010468:Perceptual Disorders / Q000139:chemically induced* / Q000188:drug therapy*; D019966:Substance-Related Disorders / Q000150:complications; D013405:Suicide / Q000523:psychology; D014796:Visual Perception / Q000187:drug effects*
chemical_list: D009271:Naltrexone; D008238:Lysergic Acid Diethylamide